Dr Ankur Mutreja, PhD, FRSB is currently a Director of External Affairs and Health Security at PATH operating from the UK and India. An experienced global health professional who has worked in industry, academia and public health, Dr Mutreja has significant expertise in R&D translation, tech-transfer, strategy, contract negotiation, tailored communication, and policy recommendation. In his previous role at CEPI where he was the country in-charge for India and Head of Global South Partnerships portfolio, he played an instrumental role in integrating R&D, Manufacturing, Access, Partnerships, Communications and Resource Mobilization plans of CEPI into a Global South Strategic Roadmap. Prior to CEPI, as a Group Leader of Global Health, he led a large international team of managers, scientists, and policy experts at the University of Cambridge where he managed several public health projects in vaccines, diagnostics, WASH, surveillance, and epidemiology. He has also served in the roles of Project Leader at the MSD-Wellcome Hilleman Laboratories and Industry-Academia Bridging Fellow at the Novartis Vaccines for Global Health, with a mission of making affordable vaccines suitable for LMIC needs. In his career, he has successfully raised funds, led, and delivered on large programs from Wellcome, WHO, BMGF, MRC, ESRC, TSB, Innovate UK, NIHR, BRC, Alborada Trust, DBT, ICMR and Hamied Foundation, among several others. Dr Mutreja has an excellent publication record and is on the board of and holds honorary positions at numerous key institutions and agencies of high repute.